EMEA-000019-PIP06-09-M05
Key facts
| Invented name |
|
| Active substance |
everolimus
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0105/2014
|
| PIP number |
EMEA-000019-PIP06-09-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Limited
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|